Skip to main content Skip to main menu
UF Health University of Florida
Division of Endocrinology, Diabetes & Metabolism Department of Medicine in the College of Medicine
Appointments: 352-273-8655
Hans K Ghayee

Hans K Ghayee, DO

Professor; VA Section Chief

Department: MD-ENDOCRINOLOGY
Business Phone: (352) 273-8662
Business Email: hans.ghayee@medicine.ufl.edu

On This Page

About Hans K Ghayee

Dr. Hans Ghayee received his osteopathic medical degree from the University of North Texas Health Science Center at Fort Worth. He did his Internal Medicine Residency at Johns Hopkins University/Sinai Hospital, followed by a fellowship in endocrinology at University of Texas Southwestern Medical Center.

Teaching Profile

Courses Taught

  1. PAS5010 – Intro to Medicine 1

    College of Medicine

  2. PAS5020 – Intro to Medicine 2

    College of Medicine

Board Certifications

  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Endocrinology, Diabetes and Metabolism

Areas of Interest

  • Adrenal Glands

Publications

Academic Articles

Grants

  1. A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

    Role:
    Principal Investigator
    Funding:
    CORCEPT THERAPEUTICS

  2. VA IPA-Yiling Xu

    Role:
    Other
    Funding:
    US DEPT OF VET AFF GAINESVILLE MED CTR

  3. Preclinical Study of a Combination Therapy for PPGL tumors with HIF2 alpha inhibitor Belzutifan plus Polyamine Analogue Inhibitor DENSPM in a PPGL Xenograft Mouse Model

    Active

    Role:
    Principal Investigator
    Funding:
    SDHB PHEO PARA COALITION

  4. Preclinical evaluation of the efficacy and mechanism of action for an alkylated polyamine analogue diethylnorspermine in treating pheochromocytoma/paraganglioma

    Role:
    Principal Investigator
    Funding:
    NATL INST OF HLTH NCATS

  5. Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant

    Role:
    Principal Investigator
    Funding:
    ICON CLINICAL RESEARCH INC via CORCEPT THERAPEUTICS

  6. VA IPA-Yiling Xu

    Role:
    Other
    Funding:
    US DEPT OF VET AFF GAINESVILLE MED CTR

  7. SDHB Coalition

    Active

    Role:
    Principal Investigator
    Funding:
    SDHB PHEO PARA COALITION

  8. VA IPA- YILING XU

    Role:
    Other
    Funding:
    US DEPT OF VET AFF GAINESVILLE MED CTR

  9. AN OPEN LABEL STUDY TO ASSESS THE SAFETY AND EFFICACY OFCOR-003 (2S, 4R-KETOCONAZOLE) IN THE TREATMENT OF ENDOGENOUS Cushing’s Syndrome

    Role:
    Principal Investigator
    Funding:
    STRONGBRIDGE BIOPHARMA

Education

  1. Fellowship – Endocrinology, Diabetes and Metabolism

    University of Texas

  2. Residency – Internal Medicine

    Johns Hopkins University

  3. Doctor of Osteopathic Medicine

    University of North Texas

Contact Details

Phones:
Business:
(352) 273-8662
Emails:
Business:
hans.ghayee@medicine.ufl.edu
Addresses:
Business Mailing:
PO Box 100226
 GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD H2
 GAINESVILLE FL 32610